Abstract:Background: Infection is the most common complication of Idiopathic Nephrotic Syndrome (INS) and the main cause of INS recurrence, severe infection and even leading to mortality. The purpose of this study was to investigate the risk factors of severe infection in INS children and the clinical parameters influencing prognosis. Methods: Totally 147 children with INS and concomitant infections were enrolled and classified into the severe infection group (SIG) and Non-severe infection group (Non-SIG). The clinical characteristics and auxiliary examination results were compared between the two groups, and the early-warning parameters for severe infection and risk factors for poor prognosis were evaluated. Results: There were 49 patients in the SIG, 98 patients in the Non-SIG. In the SIG, the most common severe infections disease included severe pneumonia (63.6%), severe sepsis (30.6%), septic shock (4.1%). In SIG, Gram-positive bacteria (GPB) were more common, as was respiratory syncytial virus (RSV), and the three most common strains were Pseudomonas aeruginosa, Staphylococcus aureus (SA) and Staphylococcus epidermidis. There were more steroid-resistant nephrotic syndrome and combination of steroids and immunosuppressants in SIG, compared with the Non-SIG ( P = 0.000). Patients in the SIG has lower complement 3 (C3, ≤ 0.55 g/L,) and absolute lymphocyte count (ALC, ≤ 1.5 × 10 9 /L) ( P = 0.004). Logistic regression analysis revealed that the independent risk factors for severe infections were the combined use of immunosuppressants [95% confidence interval (CI):1.569–463.541, P = 0.023], steroid resistance (95% CI: 4.845–2,071.880, P = 0.003), C-reactive protein (CRP) ≥8 mg/L (95% CI: 43.581–959, 935.668, P = 0.001), and infections caused by GPB (95% CI: 27.126–2,118, 452.938, P = 0.002), influenza (95% CI: 2.494–1, 932.221, P = 0.012) and RSV (95% CI: 5.011–24 963.819, P = 0.007). The patients in the SIG were classified into the survival group ( N = 39) and the mortality group ( N = 5). Logistic regression analysis showed that white blood cell count (WBC) >15 × 10 9 /L (95% CI: 1.046–2.844, P = 0.033) was an independent risk factor of poor prognosis for these patients. Conclusions: Resistance to steroids, combined with steroids and IS agents, and GPB infections (especially SA) are high-risk factors for severe infection in children with INS. We should monitor CRP ≥ 8 mg/L, C3 ≤ 0.55 g/L and ALC ≤ 1.5 × 10 9 /L to avoid developing severe infection. Accompanied by an increase in ANC, WBC significantly increased, suggesting a fatal infection.

Severe pulmonary infection as a complication of glucocorticosteroids therapy in patients with nephrotic syndrome

Diagnosis and Treatment of Severe Pulmonary Infection Accompanied in Patients with Chronic Glomerular Disease on Glucocorticoid and Immunosuppressive Therapy

[Approach of Influence Factors on Infectious Complications in Patients with Primary Nephrotic Syndrome].

Efficacy and Safety of Glucocorticoids in Treatment of COVID-19: a Retrospective Study.

Clinical study on related factors of severe pneumonia in immunosuppressed state in hospitalized patients with nephrotic syndrome

Effects of the working experience, educational background, professional titles, and hospital grades of intensive care unit doctors on clinical glucocorticoid use in acute respiratory distress syndrome

Efficacy and safety of corticosteroids for septic shock in immunocompromised patients: A cohort study from MIMIC

Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study

Glucocorticosteroid in Treatment of Severe Pneumonia

Moderate-dose glucocorticoids as salvage therapy for severe pneumonia in renal transplant recipients: a single-center feasibility study

Nocardiosis in Glomerular Disease Patients with Immunosuppressive Therapy

The Pulsing Paradox: Successful Steroid Therapy in Infection-Related Glomerulonephritis

Clinical Parameters of Pneumocystis Pneumonia in 36 Patients with Glomerular Disease

[Role of glucocorticoids in pneumocystis pneumonia in patients with non-HIV infection/AIDS (HIV/AIDS) and related mechanisms].

The Evaluation of Risk Factors and Prognostic Impact of Glucocorticoid Therapy among Non-Hiv Patients with Pneumocystis Jirovecii Pneumonia (PCP) Running Title：glucocorticoid Therapy among Non-Hiv Patients with PCP

Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.

[Clinical Characteristics and Prognosis of Long-Term Glucocorticoid Users with Community-Acquired Pneumonia].

Nocardiosis in Patients with Nephrotic Syndrome: a Retrospective Analysis of 11 Cases and a Literature Review

Management of Patients with Severe Pulmonary Infection after Renal Transplantation

Risk Factors for Poor Prognosis of Severe Infection in Children With Idiopathic Nephrotic Syndrome: A Double-Center, Retrospective Study

Severe Pneumonia in Mycophenolate Mofetil Combined with Low-Dose Corticosteroids-Treated Patients with Immunoglobulin A Nephropathy